Page last updated: 2024-08-25

zoledronic acid and Dermatitis Medicamentosa

zoledronic acid has been researched along with Dermatitis Medicamentosa in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Barua, P; Gonzalez-Mosquera, LF; Kandala, H; Podrumar, A1
Cohen, PR1
Collier, M; Mahalingam, M; Succaria, F1
Chan, JJ; Tong, PL; Yu, LL1

Reviews

1 review(s) available for zoledronic acid and Dermatitis Medicamentosa

ArticleYear
Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Dermatology online journal, 2015, Aug-15, Volume: 21, Issue:8

    Topics: Arm; Axilla; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Buttocks; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Diphosphonates; Drug Eruptions; Erythema; Female; Humans; Imidazoles; Intertrigo; Lung Neoplasms; Middle Aged; Mixed Tumor, Malignant; Syndrome; Zoledronic Acid

2015

Other Studies

3 other study(ies) available for zoledronic acid and Dermatitis Medicamentosa

ArticleYear
Zoledronic acid-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
    BMJ case reports, 2021, Sep-13, Volume: 14, Issue:9

    Topics: Drug Eruptions; Exanthema; Humans; Pharmaceutical Preparations; Zoledronic Acid

2021
Zoledronic Acid-Induced Interface Dermatitis.
    The American Journal of dermatopathology, 2015, Volume: 37, Issue:12

    Topics: Bone Density Conservation Agents; Diphosphonates; Drug Eruptions; Female; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Zoledronic Acid

2015
Drug-induced dermatomyositis after zoledronic acid.
    The Australasian journal of dermatology, 2012, Volume: 53, Issue:4

    Topics: Bone Density Conservation Agents; Dermatomyositis; Diphosphonates; Drug Eruptions; Female; Humans; Imidazoles; Middle Aged; Osteoporosis; Zoledronic Acid

2012